Abstract:Background: Curcumin (CUR) has been linked with antioxidant, anti-inflammatory, antimicrobial, anti amyloid, and antitumor effects, but its application is limited because of its low aqueous solubility and poor oral bioavailability. Methods: To improve its bioavailability and water solubility, we synthesized two series of poly (epsilon-Caprolactone)-poly (ethylene glycol)-poly (epsilon-Caprolactone) triblock copolymers by ring-opening polymerization of poly (ethylene glycol) and epsilon-Caprolactone, with stannous 2-ethylhexanoate as the catalyst. Structure of the copolymers was characterized by proton nuclear magnetic resonance spectroscopy, Fourier transform infrared spectroscopy, and gel permeation chromatography. The nanoparticles (NPs) were prepared using a probe-type ultrasonic emulsion and solvent evaporation method. To obtain an optimal delivery system, we explored the effect of the length of the copolymers' hydrophilic and hydrophobic chains on the encapsulation of hydrophobic CUR, performing entrapment efficiency and drug loading evaluations, as well as studying the particle distribution and in vitro release using the direct dispersion method. Finally, study of the in vivo pharmacokinetics of the CUR-loaded NPs was also carried out on selected copolymers in comparison with CUR solution formulations. Results: CUR was encapsulated with 94.3% and 95.5% efficiency in biodegradable nanoparticulate formulations based on NP43 and NP63, respectively. Dynamic laser light scattering and transmission electron microscopy indicated a particle diameter of 55.6 nm and 62.4 nm for NP43 and NP63, respectively. Fourier transform infrared spectroscopy and differential scanning calorimetry analysis of the NPs showed that CUR was encapsulated into the NPs. The in vitro release experiments showed that NP63 controlled the release of CUR more effectively, with only 55% of CUR released after 96 hours. In comparison with the free-drug solution in vivo, encapsulation of the CUR in NP63 increased mean residence time from 0.169 to 40.148 hours and the area under the concentration-time curve 4.178-fold. Conclusion: CUR was effectively entrapped by the prepared NPs, which could improve the solubility of CUR and prolong its retention in the systemic circulation.

Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles

N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

The Enhancement of N-acetylcysteine on Intestinal Absorption and Oral Bioavailability of Hydrophobic Curcumin.

In Vitro Characterization and in Vivo Evaluation of Nanostructured Lipid Curcumin Carriers for Intragastric Administration

A curcumin oral delivery system based on sodium caseinate and carboxymethylpachymaran nanocomposites

BSA Nanoparticles Modified with N -Acetylcysteine for Improving the Stability and Mucoadhesion of Curcumin in the Gastrointestinal Tract.

In vivo evaluation of curcumin loaded nanosuspensions by oral administration.

Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats

Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.

Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.

PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms.

Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation

Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.

Oral Delivery of Curcumin Using Silk Nano- and Microparticles

Enhancement of Transport of Curcumin to Brain in Mice by Poly(n-Butylcyanoacrylate) Nanoparticle

Oral Delivery of Curcumin Via Porous Polymeric Nanoparticles for Effective Ulcerative Colitis Therapy.

Study on the Stability and Oral Bioavailability of Curcumin Loaded (-)-epigallocatechin-3-gallate/poly(n-vinylpyrrolidone) Nanoparticles Based on Hydrogen Bonding-Driven Self-Assembly

[Preparation and Characterization of Curcumin Polybutylcyanoacrylate Nanoparticles].

Inducing Sustained Release and Improving Oral Bioavailability of Curcumin Via Chitosan Derivatives-Coated Liposomes.

Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin

Preparation, Characterization, Pharmacokinetics, and Tissue Distribution of Curcumin Nanosuspension with Tpgs As Stabilizer